EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative mapping of preexisting influenza immune landscapes predicts vaccine response

Stephanie Hao, Ivan Tomic, Benjamin B Lindsey, Ya Jankey Jagne, Katja Hoschler, Adam Meijer, Juan Manuel Carreño Quiroz, Philip Meade, Kaori Sano, Chikondi Peno, André G Costa-Martins, Debby Bogaert und 5 weitere

Journal of Clinical Investigation · 16.09.2025 · 135 (18)

DOI: 10.1172/jci189300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.07.2025. Verfasst von Stephanie Hao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Atomic Lab, National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, CD8-Positive T-Lymphocytes, Influenza A virus, Influenza Vaccines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIAID NIH HHS, Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Predicting individual vaccine responses is a substantial public health challenge. We developed Immunaut, an open-source, data-driven framework for systems vaccinologists to analyze and predict immunological outcomes across diverse vaccination settings, beyond traditional assessments. METHODS Using a comprehensive live attenuated influenza vaccine (LAIV) dataset from 244 Gambian children, Immunaut integrated prevaccination and postvaccination humoral, mucosal, cellular, and transcriptomic data. Through advanced modeling, our framework provided a holistic, systems-level view of LAIV-induced immunity. RESULTS The analysis identified 3 distinct immunophenotypic profiles driven by baseline immunity: (a) CD8 + T cell responders with strong preexisting immunity boosting memory T cell responses; (b) mucosal responders with prior influenza A virus immunity developing robust mucosal IgA and subsequent influenza B virus seroconversion; and (c) systemic, broad influenza A virus responders starting from immune naivety who mounted broad systemic antibody responses. Pathway analysis revealed how preexisting immune landscapes and baseline features, such as mucosal preparedness and cellular support, quantitatively dictate vaccine outcomes. CONCLUSION Our findings emphasize the power of integrative, predictive frameworks for advancing precision vaccinology. The Immunaut framework is a valuable resource for deciphering vaccine response heterogeneity and can be applied to optimize immunization strategies across diverse populations and vaccine platforms. FUNDING Wellcome Trust (110058/Z/15/Z); Bill & Melinda Gates Foundation (INV-004222); HIC-Vac Consortium; NIAID (R21 AI151917); NIAID CEIRR Network (75N93021C00045).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralCD8-Positive T-LymphocytesInfluenza A virusInfluenza VaccinesInfluenza, HumanChildChild, PreschoolFemaleHumansMaleVaccinationVaccines, AttenuatedDatasets as Topic

Stichwörter der Autor:innen

Adaptive immunityClinical ResearchImmunologyInfluenzaVaccinesVirology

Substanzen

Antibodies, ViralInfluenza VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • Atomic Lab, National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, Massachusetts, USA.
  • The Florey Institute of Infection and NIHR Sheffield Biomedical Research Centre, and.
  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Beech Hill Road, Sheffield, United Kingdom.
  • Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
  • Respiratory Virus Unit, Public Health Microbiology Reference Services, UK Health Security Agency, London, United Kingdom.
  • National Institute for Public Health and the Environment, Bilthoven, Netherlands.

Förderung

  • Wellcome Trust
  • NIAID NIH HHS
  • Gates Foundation
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Hao, S., Tomic, I., Lindsey, B. B., Jagne, Y. J., Hoschler, K., Meijer, A., Carreño Quiroz, J. M., Meade, P., Sano, K., Peno, C., Costa-Martins, A. G., Bogaert, D., Kampmann, B., Nakaya, H., Krammer, F., de Silva, T. I., & Tomic, A. (2025). Integrative mapping of preexisting influenza immune landscapes predicts vaccine response. Journal of Clinical Investigation, 135(18). https://doi.org/10.1172/jci189300

Vancouver

Hao S, Tomic I, Lindsey BB, Jagne YJ, Hoschler K, Meijer A, et al. Integrative mapping of preexisting influenza immune landscapes predicts vaccine response. Journal of Clinical Investigation. 2025;135(18). doi:10.1172/jci189300

BibTeX
@article{Hao2025,
  author = {Hao, Stephanie and Tomic, Ivan and Lindsey, Benjamin B and Jagne, Ya Jankey and Hoschler, Katja and Meijer, Adam and Carreño Quiroz, Juan Manuel and Meade, Philip and Sano, Kaori and Peno, Chikondi and Costa-Martins, André G and Bogaert, Debby and Kampmann, Beate and Nakaya, Helder and Krammer, Florian and de Silva, Thushan I and Tomic, Adriana},
  title = {Integrative mapping of preexisting influenza immune landscapes predicts vaccine response},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {18},
  doi = {10.1172/jci189300}
}
Kostenlos starten →